Table 2 Treatment outcomes after debridement and antibiotic therapy for infectious scleritis
From: Early surgical debridement in the management of infectious scleritis after pterygium excision
Patient | Hospital stay (days) | Complications | Antibiotic therapy | BCVA before debridement | BCVA after debridement | Follow-up (months) |
|---|---|---|---|---|---|---|
1 | 21 | Bleeding, scleral thinning, glaucoma, recurrence | Ciprofloxacin IV, gentamicin IV, tobramycin/dexamethasone gtts, ciprofloxacin ointment, fortified topical cefazolin and tobramycin and vancomycin and piperacillin gtts, ciprofloxacin ointment, ciprofloxacin PO | HM | 20/50 −2 | 86 |
2 | 2 | Severe scleral thinning, involvement of sclera at medial rectus | Levofloxacin IV, tobramycin/dexamethasone gtts, moxifloxacin gtts, gatifloxacin gtts | 20/100 | 20/40 | 30 |
3 | 1 | Scleral thinning, involvement of sclera at medial rectus | Fortified topical vancomycin and tobramycin gtts, gatifloxacin gtts, ciprofloxacin PO | 20/200 | 20/50 | 4 |
4 | 1 | Scleral thinning | Levofloxacin IV, fortified topical vancomycin and tobramycin gtts, gatifloxacin gtts, ciprofloxacin ointment | 20/100 −1 | 20/40 +2 | 14 |
5 | 3 | Scleral thinning, entropion, posterior synechiae | Cefazolin IV, fortified topical vancomycin and tobramycin gtts, ciprofloxacin gtts, moxifloxacin gtts | LP | CF | 4 |
6 | 2 | Severe scleral thinning requiring scleral patch graft and patch graft revision, involvement of sclera at medial rectus | Fortified topical vancomycin and tobramycin gtts, gatifloxacin gtts, gentamicin ointment, levofloxacin PO | 20/100 | 20/50 +1 | 5 |
7 | 1 | Scleral thinning, corneal necrosis with iris adhesion, prolapsed vitreous, elevated IOP | Levofloxacin IV, Fortified topical vancomycin and tobramycin gtts, gatifloxacin gtts, moxifloxacin gtts, moxifloxacin PO, fluconazole PO, doxycyclin PO | LP | LP | 4 |
8 | 7 | Severe scleral thinning, glaucoma | Gentamicin IV, ciprofloxacin IV, fortified topical tobramycin and vancomycin gtts, moxifloxacin gtts, loteprednol/tobramycin gtts, ciprofloxacin ointment, ciprofloxacin PO | 3/200 | 20/30 −2 | 26 |
9 | 5, 1 | Scleral thinning, recurrence | Fortified topical vancomycin and tobramycin gtts, moxifloxacin gtts, gatifloxacin gtts, ofloxacin gtts, ciprofloxacin gtts | 20/200 | HM | 44 |
10 | 0 | Scleral thinning, perforation, corneal haze, corneal epithelial defect that resolved | Fortified topical tobramycin and cefazolin gtts, ofloxacin gtts | 20/50 | 20/25 +1 | 62 |
11 | 14 | Scleral thinning, choroidal detachment, involvement of sclera under medial rectus | Ciprofloxacin IV, fortified topical tobramycin and piperacillin gtts, tobramycin/dexamethasone gtts, levofloxacin gtts, ofloxacin gtts | 20/80 +2 | 20/60 +1 | 6 |
12 | 4 | Scleral thinning, hypertrophic conjunctival growth, choroidal detachments, serous retinal detachment | Ciprofloxacin IV, fortified topical tobramycin gtts, levofloxacin gtts | 20/25 | 20/20 | 13 |
13 | 10 | Scleral thinning, phthisis | Fortified topical tobramycin and vancomycin gtts, levofloxacin gtts, ciprofloxacin ointment, ciprofloxacin PO, erythromycin gtts | CF @ 5′ | NLP | 102 |